BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 1638712)

  • 1. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin-converting enzyme inhibition.
    Volpe M; Rao MA; Cuocolo A; Russo R; Nappi A; Mele AF; Enea I; Trimarco B; Condorelli M
    Circulation; 1995 Nov; 92(9):2511-8. PubMed ID: 7586352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. The SOLVD Investigators.
    Konstam MA; Kronenberg MW; Udelson JE; Kinan D; Metherall J; Dolan N; Edens T; Howe D; Kilcoyne L; Benedict C
    Am J Cardiol; 1992 Jun; 69(19):1591-5. PubMed ID: 1598875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators.
    Pouleur H; Rousseau MF; van Eyll C; Stoleru L; Hayashida W; Udelson JA; Dolan N; Kinan D; Gallagher P; Ahn S
    Circulation; 1993 Aug; 88(2):481-91. PubMed ID: 8101772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
    Sabbah HN; Shimoyama H; Kono T; Gupta RC; Sharov VG; Scicli G; Levine TB; Goldstein S
    Circulation; 1994 Jun; 89(6):2852-9. PubMed ID: 8205701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators.
    Pouleur HG; Konstam MA; Udelson JE; Rousseau MF
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):43A-48A. PubMed ID: 8376696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contractile state is the major determinant of functional outcome in patients with left ventricular dysfunction treated with enalapril.
    Mirsky I; Aoyagi T; Ihara T; van Eyll C; Rousseau MF; Pouleur H
    Eur Heart J; 1995 Jun; 16(6):808-17. PubMed ID: 7588925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
    McKelvie RS; Yusuf S; Pericak D; Avezum A; Burns RJ; Probstfield J; Tsuyuki RT; White M; Rouleau J; Latini R; Maggioni A; Young J; Pogue J
    Circulation; 1999 Sep; 100(10):1056-64. PubMed ID: 10477530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group.
    Edner M; Bonarjee VV; Nilsen DW; Berning J; Carstensen S; Caidahl K
    Clin Cardiol; 1996 Jul; 19(7):543-8. PubMed ID: 8818434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular unloading and improvement in left ventricular function after angiotensin converting enzyme inhibition with enalapril in patients with chronic congestive heart failure.
    Naganuma F; Kubota S; Hirahara N; Imai K; Kamiyama H; Iizuka T; Imai S; Murata K; Suzuki T
    Jpn Circ J; 1994 Jan; 58(1):34-42. PubMed ID: 8139090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators.
    Hayashida W; Van Eyll C; Rousseau MF; Pouleur H
    J Am Coll Cardiol; 1993 Nov; 22(5):1403-10. PubMed ID: 8227798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
    Rastogi S; Sharov VG; Mishra S; Gupta RC; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2149-55. PubMed ID: 18820026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL; van Veldhuisen DJ; Goulder M; Zilahi Z; Meyer WR; Willenheimer R
    Int J Cardiol; 2010 Sep; 144(1):59-63. PubMed ID: 19481278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
    Greenberg B; Quinones MA; Koilpillai C; Limacher M; Shindler D; Benedict C; Shelton B
    Circulation; 1995 May; 91(10):2573-81. PubMed ID: 7743619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.